Obsessive-compulsive disorder, in other words obsessive-compulsive disorder, occurs after depression, prolonged drug use and specific phobias. This disease can occur at different periods of life in 2% of the population.

Experts from the University of Oxford suggested that since psilocybin and ocd has already been proven effective in treating depression and anxiety, it may also be useful in treating OCD.

In particular, it could be used to interrupt repetitive thoughts and actions in patients. In order to understand whether this is so, they conducted a meta-analysis of studies on this topic, says New Atlas.

Among a number of studies that do not meet modern scientific principles, they found several substantiated hypotheses explaining the benefits of adrenaline in the treatment of OCD. One of them, for example, concerned several interconnected regions of the brain - the so-called passive mode network of the brain (SPRM), which is activated in humans at rest. Its functioning is associated with rumination and daydreaming, and its dysfunction is associated with depression and anxiety.

Psilocybin appears to serve as a kind of reset button for the malfunctioning SRM that is seen in patients with OCD. Experiments have shown that one dose of the substance can temporarily disrupt the functioning of this neural network if it begins to malfunction.

And in a 2006 study, patients with moderate to severe OCD were given a dose of psilocybin every seven days for three weeks. All of them experienced temporary relief within 24 hours of taking the drug. Long-term effects were also noted, although to a lesser extent.

However, despite evidence of the psychedelic's effectiveness in the treatment of OCD and other disorders, the process of legalizing it as a medical drug is just beginning. Political and social norms impede research, and the inability to generate much profit from the sale of this natural substance, which is not subject to patents, deprives scientists of funding from pharmaceutical companies.

However, the decriminalization of psychedelics has already begun in some places. In November, residents of the US state of Oregon will hold the world's first referendum on the legalization of psychedelics. If the decision is positive, mushrooms that cause hallucinations can be grown in special institutions and taken in clinics under the supervision of doctors.